ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

NCI CTEP Approved Trials For the Month of January

January 25, 2013

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003